Release Date: 20/01/12 11:03 Summary: AZX: Shareholder Letter - Merger Update Price Sensitive: Yes Download Document 143.21KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%